PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Sep-2025 Vacaville Aesthetic Dentistry & Implants By Dr. Coral Posert Expands Services to Meet Growing Demand for Personalized Care ACCESS Newswire
09-Sep-2025 Reminder - Webcast/Conference Call to Discuss Fantastic PRIME Phase 1b Top-line Data ACCESS Newswire
09-Sep-2025 Kerecis Expands SurgiClose Silicone Fish-Skin Product Line with New Sizes for Smaller Wounds Businesswire
09-Sep-2025 Humanetics Corporation to Present at Radiation Research Society 71st Annual International Meeting Businesswire
09-Sep-2025 Cascade Bio Secures $6M to Scale Breakthrough Biocatalysts Businesswire
09-Sep-2025 Breakthrough 3D Virtual Care Debuts at athenahealth Thrive Summit ACCESS Newswire
09-Sep-2025 Nuvig Therapeutics Appoints David J. Woodhouse, Ph.D., as Chief Executive Officer and James Mackay, Ph.D., as Independent Board Chair Businesswire
09-Sep-2025 City of Hope Launches Transformative National Clinical Trials Model to Accelerate Cancer Research Businesswire
09-Sep-2025 RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO Businesswire
09-Sep-2025 Electromed, Inc. Announces Share Repurchase Authorization Businesswire
09-Sep-2025 Scribe Therapeutics Highlights Latest Data on Lp(a)-Lowering Therapy and Novel AI Platform for Next-Generation CRISPR-Based Therapeutics at Two Premier Conferences Businesswire
09-Sep-2025 Evonik and Ethris Enter Strategic Partnership to Expand Offerings for Nucleic Acid Delivery Businesswire
09-Sep-2025 Univo IRB Revolutionizes IRB Industry With Launch of AI-Powered Workflow, OneVerse® Businesswire
09-Sep-2025 TPNS Technology Offered Only by ZOLL’s remedē System Listed in Newly Released Guideline for the Treatment of Central Sleep Apnea Businesswire
09-Sep-2025 NORIT NSF-Certified Reactivation Facility Validates 99.98% PFAS Destruction Businesswire
09-Sep-2025 Europe Liver Disease Therapeutic Market Analysis Report 2025-2033 Featuring Abbott, Astellas, BMS, Gilead Sciences, GSK, F. Hoffman-La Roche, Merck, Novartis, Sanofi, Pfizer, Takeda - ResearchAndMarkets.com Businesswire
09-Sep-2025 Vyome Holdings Strengthens Leadership Team with Industry Veterans as it plans Pivotal Trial Studies Businesswire
09-Sep-2025 ATCC Receives Contract to Advance Industrial Biomanufacturing and Produce Synthetic Aviation Fuel Precursors Businesswire
09-Sep-2025 10th Annual Dangerous Goods Confidence Outlook Shows Growing Investment in Digitalization and Innovative Packaging Businesswire
09-Sep-2025 Vicero Appoints Dr. Han Myint as Chief Medical Officer Businesswire